SSA
IMGN

Schonfeld Strategic Advisors’s Immunogen Inc IMGN Stock Holding History

Schonfeld Strategic Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-36,704
Closed -$1.09M – 2528
2023
Q4 		$1.09M Sell
36,704
-355,796
-91% -$7.09M 0.01% 1004
2023
Q3 		$6.23M Buy
392,500
+15,531
+4% +$258K 0.05% 482
2023
Q2 		$7.11M Buy
+376,969
New +$4.45M 0.06% 421
2022
Q4 		– Sell
-92,603
Closed -$443K – 3152
2022
Q3 		$443K Buy
+92,603
New +$488K ﹤0.01% 1835
2022
Q1 		– Sell
-55,400
Closed -$410K – 3025
2021
Q4 		$410K Buy
+55,400
New +$344K ﹤0.01% 1367
2019
Q2 		– Sell
-21,800
Closed -$59K – 1314
2019
Q1 		$59K Buy
21,800
+6,000
+38% +$26K ﹤0.01% 999
2018
Q4 		$76K Buy
+15,800
New +$95.9K ﹤0.01% 1016
2018
Q1 		– Sell
-865,356
Closed -$5.55M – 1018
2017
Q4 		$5.55M Sell
865,356
-93,489
-10% -$577K 0.45% 54
2017
Q3 		$7.34M Sell
958,845
-177,549
-16% -$1.18M 0.67% 29
2017
Q2 		$8.08M Buy
1,136,394
+111,218
+11% +$509K 0.83% 13
2017
Q1 		$3.97M Buy
1,025,176
+250,176
+32% +$730K 0.4% 67
2016
Q4 		$1.58M Buy
+775,000
New +$1.56M 0.2% 146

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Schonfeld Strategic Advisors's IMGN Position: Q1 2024 in Review

Schonfeld Strategic Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 36,704 shares — an estimated $1.09M sold.

Schonfeld Strategic Advisors first reported a position in IMGN in Q4 2016 and held it in 12 quarters. The position peaked at $8.08M in Q2 2017. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Schonfeld Strategic Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 36,704 Immunogen Inc shares in Q1 2024, an estimated $1.09M.
  • Schonfeld Strategic Advisors first reported a position in Immunogen Inc in Q4 2016 and held it in 12 quarters.
  • Schonfeld Strategic Advisors's Immunogen Inc position peaked at $8.08M in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2024, filed 15 May 2024.